eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-IMRX-Immuneering Corporation

Immuneering Corporation IMRX

‎$‎5.35-0.50(-8.55%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Immuneering Corporation
Today
Create an eToro account to buy IMRX stock on a secure, user-friendly, multi-asset trading platform.
Buy Immuneering Corporation
Buy Immuneering Corporation
Immuneering Corporation IMRX
Buy IMRX
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
15.20
Based on analysts who covered IMRX

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Immuneering Corporation News

More about Immuneering Corporation
Immuneering Corporation is a clinical-stage biotechnology company that is engaged in the development of novel cancer immunotherapy products to disrupt the tumour microenvironment and restore the immune system’s ability to eliminate cancer cells.

Operating in the healthcare sector, Immuneering’s platform is designed to identify and target novel immune checkpoints that play a critical role in cancer progression. The company’s lead product, IMM-1-104, is a first-in-class oral therapy that targets RAS mutations, the most common genetic alterations found in human cancers.

Diversify your virtual portfolio by following IMRX shares on eToro.
VIEW MORE   

IMRX Stock Price Chart

‎-43.30‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Immuneering Corporation share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Immuneering Corporation share price today is ‎$‎5.35, reflecting a ‎-8.55‎% change over the last 24 hours and ‎-3.62‎% over the past week. The current market capitalization of IMRX is ‎$‎323.84M with an average volume in the last three months of 1.74M. The stock has a P/E ratio of -2.82 and a dividend yield of 0%. With the stock’s beta sitting at 1.22
IMRX Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎323.84M
Day’s Range
i
Shows the high and low prices of the day.
‎$‎5.21 - ‎$‎5.75
52W Range
i
Shows the high and low prices of the last year.
‎$‎0.98 - ‎$‎10.04
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.74M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-2.82
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎5.35
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-1.9
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.22
What Is Immuneering Corporation?
Immuneering Corporation is a clinical-stage biotechnology company that is engaged in the development of novel cancer immunotherapy products to disrupt the tumour microenvironment and restore the immune system’s ability to eliminate cancer cells.

Operating in the healthcare sector, Immuneering’s platform is designed to identify and target novel immune checkpoints that play a critical role in cancer progression. The company’s lead product, IMM-1-104, is a first-in-class oral therapy that targets RAS mutations, the most common genetic alterations found in human cancers.

Diversify your virtual portfolio by following IMRX shares on eToro.
Get Started

How can I buy Immuneering Corporation stocks?

To purchase Immuneering Corporation:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Immuneering Corporation (IMRX) page and place an order to buy Immuneering Corporation.
Buy IMRX
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Immuneering Corporation
Invest in Immuneering Corporation
Today
Create an eToro account to buy IMRX stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of IMRX is ‎$‎5.35.
The average price target for Immuneering Corporation is ‎$‎15.20. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Immuneering Corporation based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Immuneering Corporation is ‎$‎323.84M
Based on 5 analysts offering recommendations for IMRX in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top